SUKI IS RECOGNIZED AS A
2026 TRANSFORMATIONAL INNOVATION LEADER
Frost & Sullivan has identified the company as demonstrating best practices within the ambient clinical intelligence platform industry.
What You Need to Know about the Transformational Innovation Leadership Recognition
“Suki reinforces its market leadership by translating innovation into outcome-driven value. Clinicians using the platform consistently reclaim significant time savings, often reclaiming one to two hours per day, which allows greater focus on patient care and reduces burnout. These efficiency gains extend beyond individual efficiency and reshape how providers allocate clinical attention.”
- Tara Semon, BPR Research Analyst
“As the healthcare AI landscape shifts across funding cycles, regulatory uncertainty, and rapid advances in large language models, Suki maintains a clear, long-term view of Ambient Clinical Intelligence as a foundational element of healthcare delivery. This steadiness shapes strategic decisions, aligns investment priorities, and enables sustained progress despite external disruption.”
- Nitin Manocha, Senior Industry Analyst
Suki Named a Transformational Innovation Leader in Ambient Clinical Intelligence by Frost & Sullivan
2026 recognition highlights Suki’s innovation, clinical quality and measurable impact as Ambient Clinical Intelligence expands across the enterprise